This website is intended for Medical Professionals only. By using this site you confirm that you are a healthcare professional.

News
Secondhand Marijuana Smoke Causes Asthma ... It’s well established that secondhand smoke from cigarettes is a ... (16 Nov 2018)
Sucking Your Baby’s Pacifier May Benefit ... Many parents probably think nothing of sucking on their baby’s ... (16 Nov 2018)
Study Explores Timing of Muscle-Related ... Statins have been linked with muscle pain and other ... (14 Nov 2018)
Pilates Provides a Range of Benefits for ... A Musculoskeletal Care study is the first to investigate ... (14 Nov 2018)
Many Older Adults Do Not Take Prescribed ... In a British Journal of Clinical Pharmacology study of older ... (12 Nov 2018)
Wednesday, 20 June 2018 20:27

Obesity in women and current smoking in men predict lack of remission in early rheumatoid arthritis Featured

Rate this item
(0 votes)

Study shows 46% of women and 38% of men with early rheumatoid arthritis do not achieve remission within a year

The results of a study presented today at the Annual European Congress of Rheumatology (EULAR 2018) report that obesity in women and current smoking in men were the strongest predictors of not achieving remission in early rheumatoid arthritis (RA) within a year.1

Although early identification and aggressive treatment of RA improves outcomes, this study showed that 46% of women and 38% of men did not achieve remission in the first year despite receiving guideline-based care. Multivariable analysis highlighted that obesity more than doubled the likelihood of not achieving remission in women. Other predictors were minority status, lower education, higher tender joint counts and fatigue scores at baseline. In men, current smoking was associated with 3.5 greater odds of not achieving remission within the first year. Other predictors included older age and higher pain.1

"These results highlight the need to support physicians and empower patients to take advantage of the impact lifestyle changes can have on disease progression," said Professor Johannes W. Bijlsma, EULAR President. "We consider it essential that recommendations reach all audiences – from rheumatologists, patients and patient organisations to healthcare professionals – in order to support all in understanding how to best manage the disease."

Almost all patients within the study were initially treated with conventional synthetic disease-modifying antirheumatic drugs (csDMARDs), with three quarters being treated with methotrexate. Analysis demonstrated that not using methotrexate significantly increased the likelihood of not achieving remission in women by 28% and men by 45%.1

"Our results suggest that lifestyle changes – smoking cessation in men and weight reduction in women – as well as optimising methotrexate use may facilitate rapid reduction of inflammation, an essential goal of treatment in early rheumatoid arthritis," said Susan J. Bartlett, Professor of Medicine at McGill University (study author).

The study included 1,628 adults with early RA enrolled in the Canadian Early Arthritis Cohort (2007-16) and receiving guideline-based care. Baseline sociodemographic and RA characteristics and patient reported outcomes over 12 months were used to identify predictors of failing to achieve remission (defined as DAS28*>2.6). Participants were mostly female (72%) with an average age of 55. They had an average of two comorbidities, and symptom duration of six months.1

*DAS28: disease activity score with 28 joints examined in this assessment.


References

1 Bartlett SJ, Schieir O, Valois MF, et al. Who is not reaching remission in early RA and why? Predictors for persistent disease activity in the first year differ in men and women and are related to lifestyle and treatment. EULAR 2018; Amsterdam: Abstract OP0106.
2 van der Heijde D, et al. Common language description of the term rheumatic and musculoskeletal diseases (RMDs) for use in communication with the lay public, healthcare providers and other stakeholders endorsed by the European League Against Rheumatism (EULAR) and the American College of Rheumatology (ACR). Annals of the Rheumatic Diseases. 2018;doi:10.1136/annrheumdis-2017-212565. [Epub ahead of print].
3 EULAR. 10 things you should know about rheumatic diseases fact sheet. Available at: https://www.eular.org/myUploadData/files/10%20things%20on%20RD.pdf [Last accessed April 2018].

 


Source: European League Against Rheumatism (EULAR)
Full bibliographic information
Annual European Congress of Rheumatology (EULAR 2018) Amsterdam, The Netherlands,

Read 347 times

Latest news

Template Settings

Theme Colors

Cyan Red Green Oranges Teal

Layout

Wide Boxed Framed Rounded
Patterns for Layour: Boxed, Framed, Rounded
Top
We use cookies to improve our website. By continuing to use this website, you are giving consent to cookies being used. More details…